Health AI Advisory
by Dr. Amir Lahav

Strategy, validation, and commercialization
for medical & consumer products

A former Harvard Medical School professor and digital health leader at Pfizer, with broad experience across healthcare, life sciences, medical devices, and consumer health.

SkyMedAI helps companies build safe AI products rather than just cool features, adapt the products they’ve already built for a world run on AI, and above all, know when not to use AI at all.

“AI isn’t about brilliant algorithms,
it’s about basic ones used brilliantly.”
 The brilliance isn’t about algorithmic complexity — it’s about applying simple tools in non-obvious ways, and building human-AI teams around them with proper validation and guardrails.

• Investors
• Health Systems
• Regulators & Payers
• Pharma & Life Sciences
• Patient Advocacy Groups
• Startups & Emerging Tech
• Medtech, Healthtech & BigTech

​​​• Clinical & Scientific Validation
• Medical Devices & Patient Apps
• Wearables & Digital Endpoints
• AI Safety for Medical & Consumer
• Pharma Commercial & Clinical Trials
• Investment Strategy & Due Diligence
• Product Development & GTM Strategy

​​​• Scientific depth
​​​• Clinical expertise
• Honesty over diplomacy
​• Creative problem-solving
​​​ • Connections that open doors
​​​• Agility to see what others miss
​​​• Priority speaking at the DHAI Summit